SCHEMBL5652935

SCHEMBL5652935

CCC(CN)c1ccc(OC)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
FFAR1 O14842 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
MIF P14174 1/20 0.46
CYP17A1 P05093 1/20 0.45
AOC3 Q16853 3/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
TSHR P16473 1/20 0.42
SLC6A4 P31645 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21465820 1.00 ALDH1A1 (0.50) ALDH1A1FFAR1CYP1A2CYP2D6CYP2C19
SCHEMBL11079771 0.90 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6CYP2C19AOC3
SCHEMBL4705880 0.87 FFAR1 (0.53) ALDH1A1FFAR1CYP1A2CYP2D6CYP2C19
SCHEMBL9872486 0.85 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19MIF
SCHEMBL28236009 0.80 FFAR1 (0.51) ALDH1A1FFAR1CYP1A2CYP2D6CYP2C19
SCHEMBL11070462 0.79 AOC3 (0.49) ALDH1A1CYP1A2CYP2D6CYP2C19AOC3
SCHEMBL28288159 0.79 SLC2A1 (0.48) ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL9359028 0.78 FFAR1 (0.47) ALDH1A1FFAR1CYP1A2CYP2D6CYP2C19
SCHEMBL11609717 0.78 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2D6CYP2C19AOC3
SCHEMBL5778033 0.78 AOC3 (0.50) ALDH1A1AOC3TAAR1L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139484-A1 DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS GOSSAMER BIO SERVICES INC (US) 2021-05-13 US disclosed
US-20210139484-A1 DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS GOSSAMER BIO SERVICES INC (US) 2021-05-13 US disclosed
WO-2019200120-A1 DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS LYCERA CORPORATION (US) 2019-10-17 WO disclosed
US-7642391-B1 Palladium-catalyzed coupling of aryl halides with alkynes IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-01-05 US disclosed
US-20070249702-A1 CALCILYTIC COMPOUNDS GLAXOSMITHKLINE LLC 2007-10-25 US disclosed
US-4136100-A BLUE-VIOLET TO GREEN-BLUE DYEINGS ON CELLULOSE TEXTILES BASF AKTIENGESELLSCHAFT (DE) 1979-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139484-A1 DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS ULK1, PHKG2, PHKG1 ALDH1A1 2060/4885FFAR1 2117/4885CYP1A2 1616/4885
US-20070249702-A1 CALCILYTIC COMPOUNDS CALCR, CASR, ORAI1 ALDH1A1 4327/4885FFAR1 1096/4885CYP1A2 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.